Corcept Therapeutics
CORT
#2333
Rank
A$11.25 B
Marketcap
A$104.86
Share price
1.96%
Change (1 day)
-3.41%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): A$14.35 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.76 Billion. In 2025 the company made an earning of A$94.12 Million a decrease over its 2024 earnings that were of A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$14.35 M-84.74%
2025 A$94.12 M-58.84%
2024 A$0.22 B29.65%
2023 A$0.17 B7.2%
2022 A$0.16 B-7.05%
2021 A$0.17 B-5.01%
2020 A$0.18 B12.79%
2019 A$0.16 B26.61%
2018 A$0.13 B74.51%
2017 A$74.78 M548.72%
2016 A$11.52 M-227.03%
2015 -A$9.08 Million-79.58%
2014 -A$44.45 Million-31.79%
2013 -A$65.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.79 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.35 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.99 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.07 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.62 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.59 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$1.99 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$38.87 Million-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA